How many employees does Oxford Gene Technology (Southern) Limited have?

Oxford Gene Technology (Southern) Limited reported an average of 0 employees in the year to 31 Mar 2025.

Company No. 03247591 · Incorporated 9 Sep 1996

Oxford Gene Technology (Southern) Limited

Q: Is Oxford Gene Technology (Southern) Limited profitable?

No — Oxford Gene Technology (Southern) Limited reported a loss of £581 in the year to 31 Mar 2025.

Registered name: OXFORD GENE TECHNOLOGY (SOUTHERN) LIMITED

Oxford Gene Technology (Southern) Limited made a £581 loss in the year to 31 Mar 2025 (revenue not disclosed).

Oxford Gene Technology (Southern) Limited reported a loss of £581 in the year to 31 Mar 2025; its revenue was not disclosed. It had 0 employees. The company is classified under “research and experimental development on biotechnology” and is based in Kidlington; we hold 3 years of its filed accounts.

Profit onlySection M · Professional, scientific and technical activitiesSIC 72110Research and experimental development on biotechnology

Status: Active
Location: Kidlington, South East
Age: 30 yrs · since 1996
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Sysmex Corporation”

Latest accounts · year to 31 Mar 2025

Key figures

Small team

Revenue

—

Not disclosed in filing

Profit

−£581

Growth —

Profit margin

—

Employees

Change —

Profit / employee

—

Profitable streak

0yrs

Consecutive profitable years in our data

This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2023	31 Mar 2024	31 Mar 2025
Disclosure	Profit only	Profit only	Profit only
Profit & loss
Revenue (turnover)	—	—	—
Profit after tax	£7.1k	−£414	−£581
Profit (best available)	£7.1k	−£414	−£581
Employees (average)	0	0	0
Ratios
Profit margin	—	—	—
Growth (year on year)
Profit growth	—	▼105.8%	—
Balance sheet — indirect signals, not revenue
Cash at bank	£30.2k	£21.7k	£29.6k
Net assets	−£5.4m	−£5.4m	−£5.4m
Current assets	£127k	£118k	£126k
Debtors	£96.4k	£96.4k	£96.1k
Source	Accounts · bulk data Dec 2024	Accounts · bulk data Dec 2024	FullAccounts · bulk data Dec 2025

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: —; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now −£5.4m
Cash at bank: ▲36%; Now £29.6k
Headcount: —; Now 0
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Ownership chain

Sysmex Corporation (registered outside the UK register)ultimate parent75–100%
Oxford Gene Technology IP Limited75–100%
Oxford Gene Technology (Southern) Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (3)

Cytocell LimitedRev. £15.5m · Profit £3.4m
Oxford Gene Technology (Operations) LtdRev. £10.3m · Profit −£353k
Oxford Gene Technology LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£581), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.